Literature DB >> 15140537

Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome.

Pierre Bordachar1, Sylvain Reuter, Stephane Garrigue, Xu Caï, Mélèze Hocini, Pierre Jaïs, Michel Haïssaguerre, Jacques Clementy.   

Abstract

AIMS: This single-centre prospective study was designed to determine the incidence, therapeutic implications and prognosis of atrial arrhythmias (AA) in patients with Brugada syndrome (BS). METHODS AND
RESULTS: Fifty nine consecutive patients with BS and 31 age and gender-matched controls underwent an electrophysiological exploration and were followed-up during 34+/-13 months. The final AA incidence was 20% in BS patients vs 0% in controls (p < 0.01). Ventricular inducibility was significantly related to a history of AA (p = 0.02). The incidence of AA in patients with a spontaneous electrocardiogram of BS was 26% vs 10% in patients with a flecainide-induced electrocardiogram (p < 0.05). In patients with an indication of implantable cardioverter defibrillator (ICD), the incidence of AA reached 27% vs 13% in patients with BS but without ICD indication (p < 0.05). Inappropriate shocks due to AA episodes were observed in 14% of ICD patients vs 10.5% of appropriate shocks. Multivariate analysis identified the implantation of a single-chamber device as an independent predictive factor of inappropriate ICD discharges (p < 0.05).
CONCLUSION: BS patients exhibit an abnormally high proportion of AA. Our data strongly suggest a more advanced disease process in BS patients with spontaneous AA. Careful programming of single-chamber ICD should be recommended to avoid inappropriate discharges.

Entities:  

Mesh:

Year:  2004        PMID: 15140537     DOI: 10.1016/j.ehj.2004.01.004

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  40 in total

1.  DNA fragmentation in leukocytes following subacute low-dose nerve agent exposure.

Authors:  J R Moffett; R A Price; S M Anderson; M L Sipos; A V Moran; F C Tortella; J R Dave
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

2.  Brugada syndrome subject to depolarization abnormality of the conduction system.

Authors:  Yusuke Hosokawa; Norishige Morita; Michio Ogano; Hiroyuki Yokoyama
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

3.  Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.

Authors:  Sandeep Joshi; Farbod Raiszadeh; Walter Pierce; Jonathan S Steinberg
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

4.  Risk stratification [corrected] of Brugada syndrome revisited.

Authors:  Eyal Nof; Charles Antzelevitch
Journal:  Isr Med Assoc J       Date:  2008-06       Impact factor: 0.892

5.  [Brugada syndrome].

Authors:  Christian Wolpert; Claudia Herrera-Siklody; Ulli Parade; Christian Strotmann; Norman Rüb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-12

6.  Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction.

Authors:  Laila Guzadhur; Sarah M Pearcey; Rudolf M Duehmke; Kamalan Jeevaratnam; Anja F Hohmann; Yanmin Zhang; Andrew A Grace; Ming Lei; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2010-06-16       Impact factor: 3.657

Review 7.  Atrial fibrillation and Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

8.  Prevention of inappropriate ICD shocks in patients with Brugada syndrome.

Authors:  Christian Veltmann; Juergen Kuschyk; Rainer Schimpf; Florian Streitner; Nina Schoene; Martin Borggrefe; Christian Wolpert
Journal:  Clin Res Cardiol       Date:  2009-09-16       Impact factor: 5.460

Review 9.  Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.

Authors:  Rainer Schimpf; Christian Veltmann; Christian Wolpert; Martin Borggrefe
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

10.  Atrial fibrillation in cardiac channelopathies.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.